ArticleCurrent medicinal chemistry2026
The Current Research Landscape on Integrating Artificial Intelligence with Ultrasound Imaging for Cancer Diagnosis: A Dual-Database Bibliometric Study.
Article in Current medicinal chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
introductionEarly cancer detection is crucial for improving outcomes. Ultrasound (US) imaging is widely accessible and cost-effective but limited by operator dependency and modest tissue contrast. Over the past decade, Artificial Intelligence (AI) has been increasingly utilized to enhance ultrasound-based cancer diagnosis, yet a comprehensive overview of this research landscape remains lacking.
methodsWe conducted a dual-database bibliometric analysis of literature from the Web of Science Core Collection and Scopus database covering 2015 to April 2025, using R software, VOSviewer, and CiteSpace.
resultsThe field has grown rapidly since 2020, with 1,848 publications identified in the Web of Science dataset. China led in publication volume (n = 869) and showed the broadest international collaboration network, followed by the USA (n = 187), India (n = 113), Korea (n = 97), and Japan (n = 64). Frontiers in Oncology, Diagnostics, and Cancers were the most productive journals, while Radiology achieved the highest citation impact. Keyword co-occurrence and citation burst analyses revealed three major research hotspots. Firstly, designing deep learning-based computer-aided diagnosis models for automated cancer detection, segmentation, and classification. Secondly, embedding AI into clinical workflows to improve diagnostic accuracy and efficiency. Thirdly, developing multimodal fusion strategies to enhance diagnosis and guide prognosis and therapy. DISCUSSION: Integrating AI with US imaging shows strong potential to enhance cancer diagnosis. From algorithm refinement to clinical implementation and multimodal radiomics, AI-assisted US imaging may significantly impact cancer care.
conclusionFuture work should emphasize large, diverse datasets, multimodal integration, transparent algorithms, and prospective validation to ensure measurable patient benefits.
Indexed as
Identifiers
41716054What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.